Literature DB >> 19214948

Largamides A-C, tiglic acid-containing cyclodepsipeptides with elastase-inhibitory activity from the marine cyanobacterium Lyngbya confervoides.

Susan Matthew1, Valerie J Paul, Hendrik Luesch.   

Abstract

Three unusual tiglic acid-containing cyclodepsipeptides, possessing the revised regioisomeric structures for largamides A-C (1-3), have been isolated from the marine cyanobacterium Lyngbya confervoides collected from southeastern Florida. The two-dimensional structures were determined by NMR spectroscopy and the absolute configurations by chiral HPLC analysis of degradation products. Compounds 1-3 are moderate inhibitors of mammalian elastase activity in vitro with IC(50) values ranging from 0.53 to 1.41 microM.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19214948      PMCID: PMC2748991          DOI: 10.1055/s-0029-1185332

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  8 in total

Review 1.  Nitrogen-containing metabolites from marine cyanobacteria.

Authors:  W H Gerwick; L T Tan; N Sitachitta
Journal:  Alkaloids Chem Biol       Date:  2001

Review 2.  Cyanobacterial peptides - nature's own combinatorial biosynthesis.

Authors:  Martin Welker; Hans von Döhren
Journal:  FEMS Microbiol Rev       Date:  2006-07       Impact factor: 16.408

3.  Lyngbyastatin 4, a dolastatin 13 analogue with elastase and chymotrypsin inhibitory activity from the marine cyanobacterium Lyngbya confervoides.

Authors:  Susan Matthew; Cliff Ross; James R Rocca; Valerie J Paul; Hendrik Luesch
Journal:  J Nat Prod       Date:  2007-01       Impact factor: 4.050

4.  Largamides A-H, unusual cyclic peptides from the marine cyanobacterium Oscillatoria sp.

Authors:  Alberto Plaza; Carole A Bewley
Journal:  J Org Chem       Date:  2006-09-01       Impact factor: 4.354

5.  Lyngbyastatins 5-7, potent elastase inhibitors from Floridian marine cyanobacteria, Lyngbya spp.

Authors:  Kanchan Taori; Susan Matthew; James R Rocca; Valerie J Paul; Hendrik Luesch
Journal:  J Nat Prod       Date:  2007-10-03       Impact factor: 4.050

6.  Free fatty acids inhibit the activity of Clostridium histolyticum collagenase and human neutrophil elastase.

Authors:  Beate Rennert; Matthias F Melzig
Journal:  Planta Med       Date:  2002-09       Impact factor: 3.352

7.  Elastin fragments drive disease progression in a murine model of emphysema.

Authors:  A McGarry Houghton; Pablo A Quintero; David L Perkins; Dale K Kobayashi; Diane G Kelley; Luiz A Marconcini; Robert P Mecham; Robert M Senior; Steven D Shapiro
Journal:  J Clin Invest       Date:  2006-02-09       Impact factor: 14.808

8.  Cytosaminomycins, new anticoccidial agents produced by Streptomyces sp. KO-8119. II. Structure elucidation of cytosaminomycins A, B, C and D.

Authors:  K Shiomi; K Haneda; H Tomoda; Y Iwai; S Omura
Journal:  J Antibiot (Tokyo)       Date:  1994-07       Impact factor: 2.649

  8 in total
  13 in total

Review 1.  Survey of marine natural product structure revisions: a synergy of spectroscopy and chemical synthesis.

Authors:  Takashi L Suyama; William H Gerwick; Kerry L McPhail
Journal:  Bioorg Med Chem       Date:  2011-06-12       Impact factor: 3.641

2.  Cyclic depsipeptides, grassypeptolides D and E and Ibu-epidemethoxylyngbyastatin 3, from a Red Sea Leptolyngbya cyanobacterium.

Authors:  Christopher C Thornburg; Muralidhara Thimmaiah; Lamiaa A Shaala; Andrew M Hau; Jay M Malmo; Jane E Ishmael; Diaa T A Youssef; Kerry L McPhail
Journal:  J Nat Prod       Date:  2011-08-01       Impact factor: 4.050

Review 3.  Therapeutic potential of marine peptides in cervical and ovarian cancers.

Authors:  Salman Ahmed; Haroon Khan; Sajad Fakhri; Michael Aschner; Wai San Cheang
Journal:  Mol Cell Biochem       Date:  2021-12-02       Impact factor: 3.396

4.  Gatorbulin-1, a distinct cyclodepsipeptide chemotype, targets a seventh tubulin pharmacological site.

Authors:  Susan Matthew; Qi-Yin Chen; Ranjala Ratnayake; Charles S Fermaintt; Daniel Lucena-Agell; Francesca Bonato; Andrea E Prota; Seok Ting Lim; Xiaomeng Wang; J Fernando Díaz; April L Risinger; Valerie J Paul; Maria Ángela Oliva; Hendrik Luesch
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-02       Impact factor: 11.205

Review 5.  New peptides isolated from Lyngbya species: a review.

Authors:  Li Liu; Kathleen S Rein
Journal:  Mar Drugs       Date:  2010-06-09       Impact factor: 5.118

6.  Phylogenetic and chemical diversity of three chemotypes of bloom-forming lyngbya species (Cyanobacteria: Oscillatoriales) from reefs of southeastern Florida.

Authors:  Koty Sharp; Karen E Arthur; Liangcai Gu; Cliff Ross; Genelle Harrison; Sarath P Gunasekera; Theresa Meickle; Susan Matthew; Hendrik Luesch; Robert W Thacker; David H Sherman; Valerie J Paul
Journal:  Appl Environ Microbiol       Date:  2009-03-06       Impact factor: 4.792

7.  Tiglicamides A-C, cyclodepsipeptides from the marine cyanobacterium Lyngbya confervoides.

Authors:  Susan Matthew; Valerie J Paul; Hendrik Luesch
Journal:  Phytochemistry       Date:  2009-10-06       Impact factor: 4.072

Review 8.  Marine pharmacology in 2009-2011: marine compounds with antibacterial, antidiabetic, antifungal, anti-inflammatory, antiprotozoal, antituberculosis, and antiviral activities; affecting the immune and nervous systems, and other miscellaneous mechanisms of action.

Authors:  Alejandro M S Mayer; Abimael D Rodríguez; Orazio Taglialatela-Scafati; Nobuhiro Fusetani
Journal:  Mar Drugs       Date:  2013-07-16       Impact factor: 5.118

9.  Exploring bioactive properties of marine cyanobacteria isolated from the Portuguese coast: high potential as a source of anticancer compounds.

Authors:  Margarida Costa; Mónica Garcia; João Costa-Rodrigues; Maria Sofia Costa; Maria João Ribeiro; Maria Helena Fernandes; Piedade Barros; Aldo Barreiro; Vitor Vasconcelos; Rosário Martins
Journal:  Mar Drugs       Date:  2013-12-31       Impact factor: 5.118

Review 10.  Marine cyanobacteria compounds with anticancer properties: a review on the implication of apoptosis.

Authors:  Margarida Costa; João Costa-Rodrigues; Maria Helena Fernandes; Piedade Barros; Vitor Vasconcelos; Rosário Martins
Journal:  Mar Drugs       Date:  2012-09-28       Impact factor: 6.085

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.